Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Outset Medical, Inc.OM · Entity 7026 | Director | June 04, 2026 | June 05, 2026 |
| Zovio IncBPI · Entity 124041 | Director | May 31, 2017 | May 31, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Outset Medical, Inc.
Report date June 04, 2026 · Filed June 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 105,839 |
Reported balance
After 2026-06-04 transaction · row 1
1 source rowRow 1 · 2026-06-04 · Grant · Acquired 10,667 · Balance 105,839 F1: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders |
| Common StockSEC Table I · non-derivative | IndirectGST Trust | 83,333 |
Reported balance
Holding disclosure · report date 2026-06-04 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 83,333 |
| Common StockSEC Table I · non-derivative | IndirectHackett Family Fund | 41,666 |
Reported balance
Holding disclosure · report date 2026-06-04 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 41,666 |
Filing footnotes · ownership attribution and instrument terms
F1: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders
Zovio Inc
Report date May 31, 2017 · Filed May 31, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 1,780 |
Reported balance
After 2017-05-31 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-05-31 · Grant · Acquired 1,780 · Balance 1,780 F1: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2: Subject to the reporting person's continuing service, 100% of the restricted stock units shall vest on May 31, 2018. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F2: Subject to the reporting person's continuing service, 100% of the restricted stock units shall vest on May 31, 2018.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 04, 2026 Filed Jun 5, 2026 22:59 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 10,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-26-000039 · edgardoc.xml · nonDerivative · entry 1 HACKETT PATRICK T · CIK 0001238606 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,839 F1 · shares: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:26 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 8,983 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-25-000055 · edgardoc.xml · nonDerivative · entry 1 HACKETT PATRICK T · CIK 0001238606 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,172 F1 · shares: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders F2 · balance_after: These numbers have been adjusted to reflect the 1-for-15 reverse stock split the Issuer effected on March 20, 2025 (the "Reverse Stock Split"). Read SEC document |
| March 10, 2025 Filed Mar 11, 2025 20:19 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionSeries A Non-Voting Convertible Preferred · Derivative | 2,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001484612-25-000034 · edgardoc.xml · derivative · entry 9 HACKETT PATRICK T · CIK 0001238606 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Hackett Family Fund Disclosed balance after: 0 Underlying: Preferred Stock · 2,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date. F2 · price: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date. F2 · derivative.exercise_date: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date. F2 · derivative.expiration_date: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date. Read SEC document |
| March 10, 2025 Filed Mar 11, 2025 20:19 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionSeries A Non-Voting Convertible Preferred · Derivative | 5,000 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001484612-25-000034 · edgardoc.xml · derivative · entry 7 HACKETT PATRICK T · CIK 0001238606 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · GST Trust Disclosed balance after: 0 Underlying: Preferred Stock · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date. F2 · price: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date. F2 · derivative.exercise_date: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date. F2 · derivative.expiration_date: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date. Read SEC document |
| March 10, 2025 Filed Mar 11, 2025 20:19 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionSeries A Non-Voting Convertible Preferred · Derivative | 5,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001484612-25-000034 · edgardoc.xml · derivative · entry 5 HACKETT PATRICK T · CIK 0001238606 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Preferred Stock · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date. F2 · price: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date. F2 · derivative.exercise_date: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date. F2 · derivative.expiration_date: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date. Read SEC document |
| March 10, 2025 Filed Mar 11, 2025 20:19 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 625,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001484612-25-000034 · edgardoc.xml · nonDerivative · entry 3 HACKETT PATRICK T · CIK 0001238606 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Hackett Family Fund Disclosed balance after: 625,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") into shares of the Issuer's common stock ("Common Stock") at its Meeting of Stockholders, held on March 5, 2025, after which each share of Preferred Stock automatically converted into 250 shares of Common Stock on March 10, 2025. Read SEC document |
| March 10, 2025 Filed Mar 11, 2025 20:19 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 1,250,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001484612-25-000034 · edgardoc.xml · nonDerivative · entry 2 HACKETT PATRICK T · CIK 0001238606 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · GST Trust Disclosed balance after: 1,250,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") into shares of the Issuer's common stock ("Common Stock") at its Meeting of Stockholders, held on March 5, 2025, after which each share of Preferred Stock automatically converted into 250 shares of Common Stock on March 10, 2025. Read SEC document |
| March 10, 2025 Filed Mar 11, 2025 20:19 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 1,250,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001484612-25-000034 · edgardoc.xml · nonDerivative · entry 1 HACKETT PATRICK T · CIK 0001238606 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,292,849 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") into shares of the Issuer's common stock ("Common Stock") at its Meeting of Stockholders, held on March 5, 2025, after which each share of Preferred Stock automatically converted into 250 shares of Common Stock on March 10, 2025. Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 20:19 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantSeries A Non-Voting Convertible Preferred · Derivative | 2,500 | $200.00 Strike: $0.00 | $500,000.00 |
DisclosureSEC source: 0001484612-25-000034 · edgardoc.xml · derivative · entry 8 HACKETT PATRICK T · CIK 0001238606 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Hackett Family Fund Disclosed balance after: 2,500 Underlying: Preferred Stock · 2,500 shares Expires not disclosed F2 · derivative.exercise_price: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date. F2 · price: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date. F2 · derivative.exercise_date: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date. F2 · derivative.expiration_date: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date. Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 20:19 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantSeries A Non-Voting Convertible Preferred · Derivative | 5,000 | $200.00 Strike: $0.00 | $1,000,000.00 |
DisclosureSEC source: 0001484612-25-000034 · edgardoc.xml · derivative · entry 6 HACKETT PATRICK T · CIK 0001238606 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · GST Trust Disclosed balance after: 5,000 Underlying: Preferred Stock · 5,000 shares Expires not disclosed F2 · derivative.exercise_price: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date. F2 · price: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date. F2 · derivative.exercise_date: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date. F2 · derivative.expiration_date: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date. Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 20:19 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantSeries A Non-Voting Convertible Preferred · Derivative | 5,000 | $200.00 Strike: $0.00 | $1,000,000.00 |
DisclosureSEC source: 0001484612-25-000034 · edgardoc.xml · derivative · entry 4 HACKETT PATRICK T · CIK 0001238606 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Preferred Stock · 5,000 shares Expires not disclosed F2 · derivative.exercise_price: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date. F2 · price: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date. F2 · derivative.exercise_date: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date. F2 · derivative.expiration_date: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date. Read SEC document |
| May 29, 2024 Filed May 29, 2024 23:10 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-24-000052 · edgardoc.xml · nonDerivative · entry 1 HACKETT PATRICK T · CIK 0001238606 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,849 F1 · shares: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders Read SEC document |
| May 31, 2023 Filed May 31, 2023 23:08 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 7,681 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-23-000046 · edgardoc.xml · nonDerivative · entry 1 HACKETT PATRICK T · CIK 0001238606 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,849 F1 · kind: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders Read SEC document |
| May 31, 2022 Filed Jun 1, 2022 20:23 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 6,880 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-22-000046 · edgardoc.xml · nonDerivative · entry 1 HACKETT PATRICK T · CIK 0001238606 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,168 F1 · kind: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders Read SEC document |
| June 03, 2021 Filed Jun 4, 2021 21:02 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 3,288 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-21-000021 · edgardoc.xml · nonDerivative · entry 1 HACKETT PATRICK T · CIK 0001238606 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,288 F1 · shares: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders Read SEC document |
| May 31, 2017 Filed May 31, 2017 18:50 UTC | Zovio Inc BPI · Entity 124041 | GrantRestricted Stock Unit · Derivative | 1,780 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-023164 · doc1.xml · derivative · entry 1 HACKETT PATRICK T · CIK 0001238606 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,780 Underlying: Common Stock · 1,780 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: Subject to the reporting person's continuing service, 100% of the restricted stock units shall vest on May 31, 2018. F2 · derivative.expiration_date: Subject to the reporting person's continuing service, 100% of the restricted stock units shall vest on May 31, 2018. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 19:53 UTC | Zovio Inc BPI · Entity 124041 | Exercise / conversionRestricted Stock Unit · Derivative | 2,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-014231 · doc1.xml · derivative · entry 5 HACKETT PATRICK T · CIK 0001238606 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,900 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F8 · derivative.exercise_date: On March 29, 2017, 100% of the restricted stock units vested and were settled for an equal number of shares of the issuer's common stock. F8 · derivative.expiration_date: On March 29, 2017, 100% of the restricted stock units vested and were settled for an equal number of shares of the issuer's common stock. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 19:53 UTC | Zovio Inc BPI · Entity 124041 | GrantRestricted Stock Unit · Derivative | 2,840 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-014231 · doc1.xml · derivative · entry 4 HACKETT PATRICK T · CIK 0001238606 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,840 Underlying: Common Stock · 2,840 shares Expires not disclosed F6 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F7 · derivative.exercise_date: Subject to the reporting person's continuing service, 100% of the restricted stock units shall vest on March 29, 2018. F7 · derivative.expiration_date: Subject to the reporting person's continuing service, 100% of the restricted stock units shall vest on March 29, 2018. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 19:53 UTC | Zovio Inc BPI · Entity 124041 | GrantStock Option (right to buy) · Derivative | 6,100 | $0.00 Strike: $10.44 | $0.00 |
DisclosureSEC source: 0001140361-17-014231 · doc1.xml · derivative · entry 3 HACKETT PATRICK T · CIK 0001238606 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,100 Underlying: Common Stock · 6,100 shares Expires 2027-03-29 F5 · derivative.exercise_date: Subject to the reporting person's continuing service, 100% of the shares subject to the option shall vest and become exercisable on March 29, 2018. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 19:53 UTC | Zovio Inc BPI · Entity 124041 | Exercise / conversionCommon Stock | 2,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-014231 · doc1.xml · nonDerivative · entry 1 HACKETT PATRICK T · CIK 0001238606 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,881 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On March 29, 2017, 2,900 of the reporting person's restricted stock units were settled for an equal number of shares of the issuer's common stock. Read SEC document |
| March 10, 2017 Filed Mar 14, 2017 17:01 UTC | Zovio Inc BPI · Entity 124041 | Disposition to issuerCommon Stock, par value $0.01 per share (''Common Stock'') | 18,072,289 | $8.30 | $149,999,998.70 |
DisclosureSEC source: 0001104659-17-016395 · a4.xml · nonDerivative · entry 1 HACKETT PATRICK T · CIK 0001238606 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 9,638,285 F1 · kind: The reported securities were sold in connection with the repurchase of Common Stock from Warburg Pincus Private Equity VIII, L.P., by Bridgepoint Education, Inc. (the "Company"), pursuant to the Share Repurchase Agreement by and between Warburg Pincus Private Equity VIII, L.P. and the Company, dated as of March 10, 2017. Pursuant to such agreement, Warburg Pincus Private Equity VIII, L.P sold 18,072,289 shares of Common Stock of the Company at $8.30 per share on March 10, 2017. F2 · ownership.nature: Reflects the Common Stock held by Warburg Pincus Private Equity VIII, L.P., a Delaware limited partnership (together with its two affiliated partnerships, "WP VIII"). The reporting person is a director of the Company, Member and Managing Director of Warburg Pincus LLC, a New York limited liability company ("WP LLC"), and a Partner of Warburg Pincus & Co., a New York general partnership ("WP"). Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the general partner, both directly and indirectly, of WP VIII. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. WP is the managing member of WP Partners GP. F3 · ownership.nature: WP LLC is the manager of WP VIII. As a result, the reporting person may be deemed to have an indirect pecuniary interest (within the meaning of Rule 16a-1 of the Securities Exchange Act of 1934, as amended (the "Exchange Act")) in an indeterminate portion of the securities that may be deemed to be beneficially owned by WP VIII, WP Partners, WP Partners GP, WP and WP LLC (collectively, the "Warburg Pincus Entities"). F4 · ownership.nature: All shares of Common Stock indicated as indirectly owned by Mr. Hackett are included because of his affiliation with the Warburg Pincus Entities. The reporting person disclaims beneficial ownership of all securities that may be deemed to be beneficially owned by the Warburg Pincus Entities, except to the extent of any indirect pecuniary interest therein. This Form 4 shall not be deemed an admission that the reporting person or any other person referred to herein is a beneficial owner of any securities for purposes of Section 16 of the Exchange Act or for any other purposes. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.